Search

everythinglearnresearchcommunity

for

Search:↓

3α‐OH‐DHP is essential for reducing nerve activity related to blood pressure control during pregnancy.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Oral testosterone therapy raises heart risk more than other methods.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

The woman's symptoms and tests suggest her adrenal glands are producing too many male hormones.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

Dutasteride injections can help treat hair loss in men and women.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

Clascoterone may be a promising treatment for hair loss.

Eurycoma longifolia extract may help increase testosterone levels and reduce andropause symptoms.

Dutasteride improved hair density and thickness in men not helped by finasteride, with minimal side effects.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

In 2017, a new method was created to efficiently produce a topical antiandrogen, a compound used to treat excess sebum and acne, with a high yield and purity.

Testosterone, DHT, and estradiol significantly affect hair cell growth.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Finasteride helps hair growth by reducing DHT levels.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Synthetic hormone treatment reduces melanin and hair growth in rats.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.